These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 19452240

  • 21. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
    Takeuchi S, Hiromura K, Tomioka M, Takahashi S, Sakairi T, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Nephron Exp Nephrol; 2010; 116(1):e3-10. PubMed ID: 20502051
    [Abstract] [Full Text] [Related]

  • 22. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.
    Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, Hori M.
    J Am Soc Nephrol; 2003 Apr; 14(4):981-91. PubMed ID: 12660332
    [Abstract] [Full Text] [Related]

  • 23. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats.
    Zhu C, Huang S, Ding G, Yuan Y, Chen Q, Pan X, Chen R, Zhang A.
    Pediatr Nephrol; 2011 Jun; 26(6):905-13. PubMed ID: 21359962
    [Abstract] [Full Text] [Related]

  • 24. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K, Matsui K, Nagase M.
    Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
    [Abstract] [Full Text] [Related]

  • 25. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
    Xing Y, Ding J, Fan Q, Guan N.
    Exp Biol Med (Maywood); 2006 May; 231(5):585-93. PubMed ID: 16636307
    [Abstract] [Full Text] [Related]

  • 26. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
    Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I.
    Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
    [Abstract] [Full Text] [Related]

  • 27. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
    Sun W, Li CQ, Chen JH, Shao JD, Zhou D, Zhang L, Gao K.
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
    [Abstract] [Full Text] [Related]

  • 28. Renoprotective effect of vasopressin v2 receptor antagonist tolvaptan in Dahl rats with end-stage heart failure.
    Ishikawa M, Kobayashi N, Sugiyama F, Onoda S, Ishimitsu T.
    Int Heart J; 2013 Jan; 54(2):98-106. PubMed ID: 23676370
    [Abstract] [Full Text] [Related]

  • 29. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
    Fukuda A, Fujimoto S, Iwatsubo S, Kawachi H, Kitamura K.
    Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
    [Abstract] [Full Text] [Related]

  • 30. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.
    Wang L, Ellis MJ, Fields TA, Howell DN, Spurney RF.
    Kidney Blood Press Res; 2008 Apr; 31(2):111-21. PubMed ID: 18367845
    [Abstract] [Full Text] [Related]

  • 31. Protective effects of PPARγ agonist in acute nephrotic syndrome.
    Zuo Y, Yang HC, Potthoff SA, Najafian B, Kon V, Ma LJ, Fogo AB.
    Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
    [Abstract] [Full Text] [Related]

  • 32. Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
    Takahashi A, Fukusumi Y, Yamazaki M, Kayaba M, Kitazawa Y, Tomita M, Kawachi H.
    J Nephrol; 2014 Dec; 27(6):627-34. PubMed ID: 25298195
    [Abstract] [Full Text] [Related]

  • 33. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
    Xiao HQ, Shi W, Liu SX, Zhang B, Xu LX, Liang XL, Liang YZ.
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
    [Abstract] [Full Text] [Related]

  • 34. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
    Shimo T, Adachi Y, Yamanouchi S, Tsuji S, Kimata T, Umezawa K, Okigaki M, Takaya J, Ikehara S, Kaneko K.
    Am J Nephrol; 2013 Jul; 37(4):302-9. PubMed ID: 23548793
    [Abstract] [Full Text] [Related]

  • 35. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
    Kinugasa S, Tojo A, Sakai T, Tsumura H, Takahashi M, Hirata Y, Fujita T.
    Kidney Int; 2011 Dec; 80(12):1328-38. PubMed ID: 21849973
    [Abstract] [Full Text] [Related]

  • 36. Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney.
    Yaoita E, Kurihara H, Yoshida Y, Inoue T, Matsuki A, Sakai T, Yamamoto T.
    Kidney Int; 2005 Aug; 68(2):542-51. PubMed ID: 16014031
    [Abstract] [Full Text] [Related]

  • 37. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

  • 38. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I, Nakamura T, Tomino Y, Koide H.
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [Abstract] [Full Text] [Related]

  • 39. Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
    Kino J, Tsuji S, Kitao T, Akagawa Y, Yamanouchi S, Kimata T, Kaneko K.
    Pediatr Res; 2018 May; 83(5):1041-1048. PubMed ID: 29360807
    [Abstract] [Full Text] [Related]

  • 40. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H, Shi W, Liu S, Wang W, Zhang B, Zhang Y, Xu L, Liang X, Liang Y.
    Am J Nephrol; 2009 May; 30(1):34-43. PubMed ID: 19202327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.